Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NYMOX PHARMACEUTICAL CORP | 4,782,065 | reported | 27 Apr 2023 | tx 379+3,818,530 |
| Allied Corp. | 4,782,065 | reported | 27 Apr 2023 | tx 2+80,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2023 | PURCHASE | Allied Corp. | 40,000 | 0.47 USD | |
| 25 Apr 2023 | PURCHASE | Allied Corp. | 40,000 | 0.45 USD | |
| 02 May 2022 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 1,151,515 | 1.65 USD | first after silenceanomaly |
| 02 May 2022 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 1,151,515 | 0.00 USD | deriv |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 51 | 2.08 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 800 | 2.10 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 4,949 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 5,000 | 2.05 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 3,100 | 2.11 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 1,900 | 2.13 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 7,000 | 2.07 USD | |
| 21 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 900 | 2.08 USD | |
| 21 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 4,100 | 2.08 USD | |
| 21 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 6,000 | 2.08 USD | first after silence |
| 21 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 2,000 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 200 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 2,900 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 1,100 | 2.09 USD | |
| 10 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 100 | 1.72 USD | |
| 10 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 166 | 1.73 USD | |
| 10 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 600 | 1.72 USD | |
| 10 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 300 | 1.73 USD | |
| 10 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 5,834 | 1.73 USD | |
| 09 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 7,000 | 1.63 USD | |
| 05 Jul 2019 | PURCHASE | NYMOX PHARMACEUTICAL CORP | 9,000 | 1.45 USD |
2 purchases reported after at least 12 months of silence — most recent on 02 May 2022.